Celebrating more than 70 years of Making Cancer History, The University of Texas MD Anderson Cancer Center is located in Houston, Texas, on the sprawling campus of the Texas Medical Center. It is one of the world's most respected centers devoted exclusively to cancer patient care, research, education and prevention.
MD Anderson was created by the Texas Legislature in 1941 as a component of The University of Texas System, and the faculty numbers 1,272 – both M.D.s and Ph.D.s. MD Anderson is one of the nation's original three Comprehensive Cancer Centers designated by the National Cancer Act of 1971 and is one of 39 Comprehensive Cancer Centers today.
MD Anderson has ranked among the nation's top two cancer hospitals in U.S. News & World Reports "America's Best Hospitals" survey since its inception in 1990. MD Anderson has ranked number one five times in the last eight years.
Since 1944, more than 700,000 patients have turned to MD Anderson for cancer care in the form of surgery, chemotherapy, radiation therapy, immunotherapy or combinations of these and other treatments. This multidisciplinary approach to treating cancer was pioneered at MD Anderson. Because they focus only on cancer, experts here are renowned for their ability to treat all types of cancer, including rare or uncommon diseases.
This year, more than 85,000 persons with cancer will receive care at MD Anderson, and about 29,000 of them will be new patients. Approximately one-third of these patients come from outside Texas seeking the research-based care that has made MD Anderson so widely respected. More than 11,000 patients participated in therapeutic clinical research exploring novel therapies and diagnostic tests in 2005, the largest such program in the nation.
MD Anderson holds accreditation from the Joint Commission on Accreditation of Healthcare Organizations (JCAHO). In 2006, the American Nurses Credentialing Center renewed the Magnet Nursing Services Recognition designation at MD Anderson, an honor first earned in 2001.
At MD Anderson, important scientific knowledge gained in the laboratory is rapidly translated into clinical care. In 2005, the institution spent more than $342 million in research, an increase of approximately 86% in the last five years. MD Anderson now ranks first in the number of grants awarded and total amount of grants given by the National Cancer Institute. MD Anderson holds 10 NCI Specialized Programs of Research Excellence (SPORE) grants: lung, bladder, prostate, ovarian, head and neck, pancreatic and endometrial cancers, leukemia, breast and melanoma. The research program is considered one of the most productive efforts in the world aimed solely at cancer.
The new Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer is composed of six unique centers focused on genomics, proteomics, screening, diagnostic imaging and drug development. Located on the 116-acre University of Texas Research Park about 1.5 miles south of the main campus, the McCombs Institute houses approximately 25% of MD Anderson’s research activities.
More than 5,500 students take part in educational programs each year, which includes physicians, scientists, nurses and many health professionals.MD Anderson's School of Health Professions offers bachelor’s degrees in eight allied health disciplines .
In addition, more than 1,000 clinical residents and fellows come to MD Anderson each year to receive specialized training in the investigation and treatment of cancer. More than 500 graduate students are working on advanced degrees at the Graduate School of Biomedical Sciences, which MD Anderson runs jointly with The University of Texas Health Science Center at Houston. More than 1,400 research fellows are being trained in MD Anderson’s laboratories.
Thousands more participate in continuing education and distance learning opportunities sponsored by MD Anderson, sharing knowledge around the globe. Likewise, MD Anderson provides public education programs to teach healthy individuals about cancer symptoms and risk factors, and how to make critical health care decisions when necessary.
Recognizing that, ultimately, prevention is the best way to eliminate the threat of cancer, MD Anderson has initiated a multifaceted effort. Expanded research efforts in epidemiology and behavioral sciences complement achievements made in the clinical cancer prevention arena. Laboratory activities support developmental and practical applications of cancer prevention. A new research program will focus attention on disparities in prevention and care among ethnic minorities and medically underserved populations.
The Cancer Prevention Center provides comprehensive cancer screening services, including cancer risk assessment, screening exams based on age and gender, personalized risk-reduction strategies, genetic testing, chemoprevention, tobacco cessation and nutrition counseling.
MD Anderson now employs more than 17,000 people and enjoys a volunteer workforce of about 1,500 volunteers who provide more than 250,000 hours of service each year. Faculty, staff and volunteers are dedicated to the core values of Caring, Integrity , Discovery and Education. Together, they work toward fulfilling the MD Anderson mission of eliminating cancer as a major health threat.
The institution has increased about 50% in size in the last five years. The physical plant includes an in-patient pavilion with 512 beds, two research buildings, an outpatient clinic building, a faculty office building and a patient-family hotel. From 2005 to present, the George and Cynthia Mitchell Basic Sciences Research Building, the Ambulatory Clinical Building, the Cancer Prevention Center, the South Campus research center and the Proton Therapy Center.